Global Sickle Cell Disease Treatments Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
SKU ID :GIR-13091035 | Published Date: 02-Nov-2018 | No. of pages: 119Description
TOC
Table of Contents
1 Sickle Cell Disease Treatments Market Overview
1.1 Product Overview and Scope of Sickle Cell Disease Treatments
1.2 Classification of Sickle Cell Disease Treatments by Types
1.2.1 Global Sickle Cell Disease Treatments Revenue Comparison by Types (2017-2023)
1.2.2 Global Sickle Cell Disease Treatments Revenue Market Share by Types in 2017
1.2.3 Infection Prevention with Vaccination and Antibiotics
1.2.4 Blood Transfusion
1.2.5 The Medication Hydroxycarbamide
1.2.6 A Transplant of Bone Marrow Cells
1.3 Global Sickle Cell Disease Treatments Market by Application
1.3.1 Global Sickle Cell Disease Treatments Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Clinics
1.3.5 Others
1.4 Global Sickle Cell Disease Treatments Market by Regions
1.4.1 Global Sickle Cell Disease Treatments Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Sickle Cell Disease Treatments Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Sickle Cell Disease Treatments Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sickle Cell Disease Treatments Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Sickle Cell Disease Treatments Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sickle Cell Disease Treatments Status and Prospect (2013-2023)
1.5 Global Market Size of Sickle Cell Disease Treatments (2013-2023)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Sickle Cell Disease Treatments Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Sickle Cell Disease Treatments Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bristol-Myers Squibb
2.3.1 Business Overview
2.3.2 Sickle Cell Disease Treatments Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bristol-Myers Squibb Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Sickle Cell Disease Treatments Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Sickle Cell Disease Treatments Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
2.6 Baxter
2.6.1 Business Overview
2.6.2 Sickle Cell Disease Treatments Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Baxter Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
2.7 Emmaus Life Sciences
2.7.1 Business Overview
2.7.2 Sickle Cell Disease Treatments Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Emmaus Life Sciences Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bluebird Bio
2.8.1 Business Overview
2.8.2 Sickle Cell Disease Treatments Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bluebird Bio Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
2.9 Global Blood Therapeutics
2.9.1 Business Overview
2.9.2 Sickle Cell Disease Treatments Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Global Blood Therapeutics Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sangamo Therapeutics
2.10.1 Business Overview
2.10.2 Sickle Cell Disease Treatments Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sangamo Therapeutics Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
2.11 Acceleron Pharma
2.11.1 Business Overview
2.11.2 Sickle Cell Disease Treatments Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Acceleron Pharma Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
2.12 Arena Pharmaceuticals
2.12.1 Business Overview
2.12.2 Sickle Cell Disease Treatments Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Arena Pharmaceuticals Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
2.13 Alnylam Pharmaceuticals
2.13.1 Business Overview
2.13.2 Sickle Cell Disease Treatments Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Alnylam Pharmaceuticals Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
3 Global Sickle Cell Disease Treatments Market Competition, by Players
3.1 Global Sickle Cell Disease Treatments Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Sickle Cell Disease Treatments Players Market Share
3.2.2 Top 10 Sickle Cell Disease Treatments Players Market Share
3.3 Market Competition Trend
4 Global Sickle Cell Disease Treatments Market Size by Regions
4.1 Global Sickle Cell Disease Treatments Revenue and Market Share by Regions
4.2 North America Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
4.3 Europe Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
4.5 South America Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
5 North America Sickle Cell Disease Treatments Revenue by Countries
5.1 North America Sickle Cell Disease Treatments Revenue by Countries (2013-2018)
5.2 USA Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
5.3 Canada Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
5.4 Mexico Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
6 Europe Sickle Cell Disease Treatments Revenue by Countries
6.1 Europe Sickle Cell Disease Treatments Revenue by Countries (2013-2018)
6.2 Germany Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
6.3 UK Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
6.4 France Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
6.5 Russia Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
6.6 Italy Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Sickle Cell Disease Treatments Revenue by Countries
7.1 Asia-Pacific Sickle Cell Disease Treatments Revenue by Countries (2013-2018)
7.2 China Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
7.3 Japan Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
7.4 Korea Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
7.5 India Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
8 South America Sickle Cell Disease Treatments Revenue by Countries
8.1 South America Sickle Cell Disease Treatments Revenue by Countries (2013-2018)
8.2 Brazil Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
8.3 Argentina Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
8.4 Colombia Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Sickle Cell Disease Treatments by Countries
9.1 Middle East and Africa Sickle Cell Disease Treatments Revenue by Countries (2013-2018)
9.2 Saudi Arabia Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
9.3 UAE Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
9.4 Egypt Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
9.5 Nigeria Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
9.6 South Africa Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
10 Global Sickle Cell Disease Treatments Market Segment by Type
10.1 Global Sickle Cell Disease Treatments Revenue and Market Share by Type (2013-2018)
10.2 Global Sickle Cell Disease Treatments Market Forecast by Type (2018-2023)
10.3 Infection Prevention with Vaccination and Antibiotics Revenue Growth Rate (2013-2023)
10.4 Blood Transfusion Revenue Growth Rate (2013-2023)
10.5 The Medication Hydroxycarbamide Revenue Growth Rate (2013-2023)
10.6 A Transplant of Bone Marrow Cells Revenue Growth Rate (2013-2023)
11 Global Sickle Cell Disease Treatments Market Segment by Application
11.1 Global Sickle Cell Disease Treatments Revenue Market Share by Application (2013-2018)
11.2 Sickle Cell Disease Treatments Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Clinics Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)
12 Global Sickle Cell Disease Treatments Market Size Forecast (2018-2023)
12.1 Global Sickle Cell Disease Treatments Market Size Forecast (2018-2023)
12.2 Global Sickle Cell Disease Treatments Market Forecast by Regions (2018-2023)
12.3 North America Sickle Cell Disease Treatments Revenue Market Forecast (2018-2023)
12.4 Europe Sickle Cell Disease Treatments Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Sickle Cell Disease Treatments Revenue Market Forecast (2018-2023)
12.6 South America Sickle Cell Disease Treatments Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Sickle Cell Disease Treatments Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Tables & Figures
List of Tables and Figures
Figure Sickle Cell Disease Treatments Picture
Table Product Specifications of Sickle Cell Disease Treatments
Table Global Sickle Cell Disease Treatments and Revenue (Million USD) Market Split by Product Type
Figure Global Sickle Cell Disease Treatments Revenue Market Share by Types in 2017
Figure Infection Prevention with Vaccination and Antibiotics Picture
Figure Blood Transfusion Picture
Figure The Medication Hydroxycarbamide Picture
Figure A Transplant of Bone Marrow Cells Picture
Table Global Sickle Cell Disease Treatments Revenue (Million USD) by Application (2013-2023)
Figure Sickle Cell Disease Treatments Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Sickle Cell Disease Treatments Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Sickle Cell Disease Treatments Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Sickle Cell Disease Treatments Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Sickle Cell Disease Treatments Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Sickle Cell Disease Treatments Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Sickle Cell Disease Treatments Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Sickle Cell Disease Treatments Revenue (Million USD) and Growth Rate (2013-2023)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Sickle Cell Disease Treatments Type and Applications
Table AstraZeneca Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Sickle Cell Disease Treatments Type and Applications
Table Eli Lilly Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Sickle Cell Disease Treatments Type and Applications
Table Bristol-Myers Squibb Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Sickle Cell Disease Treatments Type and Applications
Table Novartis Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Sickle Cell Disease Treatments Type and Applications
Table Pfizer Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
Table Baxter Basic Information, Manufacturing Base and Competitors
Table Baxter Sickle Cell Disease Treatments Type and Applications
Table Baxter Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
Table Emmaus Life Sciences Basic Information, Manufacturing Base and Competitors
Table Emmaus Life Sciences Sickle Cell Disease Treatments Type and Applications
Table Emmaus Life Sciences Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
Table Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table Bluebird Bio Sickle Cell Disease Treatments Type and Applications
Table Bluebird Bio Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
Table Global Blood Therapeutics Basic Information, Manufacturing Base and Competitors
Table Global Blood Therapeutics Sickle Cell Disease Treatments Type and Applications
Table Global Blood Therapeutics Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
Table Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table Sangamo Therapeutics Sickle Cell Disease Treatments Type and Applications
Table Sangamo Therapeutics Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
Table Acceleron Pharma Basic Information, Manufacturing Base and Competitors
Table Acceleron Pharma Sickle Cell Disease Treatments Type and Applications
Table Acceleron Pharma Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
Table Arena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Arena Pharmaceuticals Sickle Cell Disease Treatments Type and Applications
Table Arena Pharmaceuticals Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alnylam Pharmaceuticals Sickle Cell Disease Treatments Type and Applications
Table Alnylam Pharmaceuticals Sickle Cell Disease Treatments Revenue, Gross Margin and Market Share (2016-2017)
Table Global Sickle Cell Disease Treatments Revenue (Million USD) by Players (2013-2018)
Table Global Sickle Cell Disease Treatments Revenue Share by Players (2013-2018)
Figure Global Sickle Cell Disease Treatments Revenue Share by Players in 2016
Figure Global Sickle Cell Disease Treatments Revenue Share by Players in 2017
Figure Global Top 5 Players Sickle Cell Disease Treatments Revenue Market Share in 2017
Figure Global Top 10 Players Sickle Cell Disease Treatments Revenue Market Share in 2017
Figure Global Sickle Cell Disease Treatments Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Sickle Cell Disease Treatments Revenue (Million USD) by Regions (2013-2018)
Table Global Sickle Cell Disease Treatments Revenue Market Share by Regions (2013-2018)
Figure Global Sickle Cell Disease Treatments Revenue Market Share by Regions (2013-2018)
Figure Global Sickle Cell Disease Treatments Revenue Market Share by Regions in 2017
Figure North America Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure Europe Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure South America Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Table North America Sickle Cell Disease Treatments Revenue by Countries (2013-2018)
Table North America Sickle Cell Disease Treatments Revenue Market Share by Countries (2013-2018)
Figure North America Sickle Cell Disease Treatments Revenue Market Share by Countries (2013-2018)
Figure North America Sickle Cell Disease Treatments Revenue Market Share by Countries in 2017
Figure USA Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure Canada Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure Mexico Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Table Europe Sickle Cell Disease Treatments Revenue (Million USD) by Countries (2013-2018)
Figure Europe Sickle Cell Disease Treatments Revenue Market Share by Countries (2013-2018)
Figure Europe Sickle Cell Disease Treatments Revenue Market Share by Countries in 2017
Figure Germany Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure UK Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure France Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure Russia Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure Italy Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Sickle Cell Disease Treatments Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Sickle Cell Disease Treatments Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Sickle Cell Disease Treatments Revenue Market Share by Countries in 2017
Figure China Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure Japan Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure Korea Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure India Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Table South America Sickle Cell Disease Treatments Revenue by Countries (2013-2018)
Table South America Sickle Cell Disease Treatments Revenue Market Share by Countries (2013-2018)
Figure South America Sickle Cell Disease Treatments Revenue Market Share by Countries (2013-2018)
Figure South America Sickle Cell Disease Treatments Revenue Market Share by Countries in 2017
Figure Brazil Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure Argentina Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure Colombia Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Sickle Cell Disease Treatments Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Sickle Cell Disease Treatments Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Sickle Cell Disease Treatments Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Sickle Cell Disease Treatments Revenue Market Share by Countries in 2017
Figure Saudi Arabia Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure UAE Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure Egypt Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure Nigeria Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Figure South Africa Sickle Cell Disease Treatments Revenue and Growth Rate (2013-2018)
Table Global Sickle Cell Disease Treatments Revenue (Million USD) by Type (2013-2018)
Table Global Sickle Cell Disease Treatments Revenue Share by Type (2013-2018)
Figure Global Sickle Cell Disease Treatments Revenue Share by Type (2013-2018)
Figure Global Sickle Cell Disease Treatments Revenue Share by Type in 2017
Table Global Sickle Cell Disease Treatments Revenue Forecast by Type (2018-2023)
Figure Global Sickle Cell Disease Treatments Market Share Forecast by Type (2018-2023)
Figure Global Infection Prevention with Vaccination and Antibiotics Revenue Growth Rate (2013-2018)
Figure Global Blood Transfusion Revenue Growth Rate (2013-2018)
Figure Global The Medication Hydroxycarbamide Revenue Growth Rate (2013-2018)
Figure Global A Transplant of Bone Marrow Cells Revenue Growth Rate (2013-2018)
Table Global Sickle Cell Disease Treatments Revenue by Application (2013-2018)
Table Global Sickle Cell Disease Treatments Revenue Share by Application (2013-2018)
Figure Global Sickle Cell Disease Treatments Revenue Share by Application (2013-2018)
Figure Global Sickle Cell Disease Treatments Revenue Share by Application in 2017
Table Global Sickle Cell Disease Treatments Revenue Forecast by Application (2018-2023)
Figure Global Sickle Cell Disease Treatments Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Sickle Cell Disease Treatments Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Sickle Cell Disease Treatments Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Sickle Cell Disease Treatments Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Sickle Cell Disease Treatments Revenue Market Forecast (2018-2023)
Figure Europe Sickle Cell Disease Treatments Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Sickle Cell Disease Treatments Revenue Market Forecast (2018-2023)
Figure South America Sickle Cell Disease Treatments Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Sickle Cell Disease Treatments Revenue Market Forecast (2018-2023)
Companies
AstraZeneca
Eli Lilly
Bristol-Myers Squibb
Novartis
Pfizer
Baxter
Emmaus Life Sciences
Bluebird Bio
Global Blood Therapeutics
Sangamo Therapeutics
Acceleron Pharma
Arena Pharmaceuticals
Alnylam Pharmaceuticals
- PRICE
-
$3480$6960